Early Success in Trials: Gynica Anticipates 2021 Clinical Launch

March 2020

Gynica’s preclinical studies for a cannabinoid-based treatment for gynecological disorders are already showing promising results. The study is led by Prof. Lumir Ondrej Hanus, the chemist responsible for the definition and isolation of active cannabinoid compounds in 1992.

This Week’s Top Cannabis News: Stocks In Bright Green, Corporate News, And A Congressional Hearing

Jan 2020

Gynica and Lumir Lab announced they have formed a partnership focused on finding a cannabis-based treatment for endometriosis, a topic discussed in a recent Forbes article featuring Lara Parker.